Therefore, materials inhibiting nitric oxide (NO) production by repressing inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) enzymes can be used as adjuvant anti-type 2 diabetic agents. This evidence concerns the gene PTGS2 and type 2 diabetes mellitus.